Dr. Stacey Clardy and Dr. Nicola de Souza discuss how to improve care in the clinic for these veterans and military service members.

Show reference:

https://www.neurology.org/doi/10.1212/WNL.0000000000209417

In the first installment of this two-part series, Dr. Jeff Ratliff and Dr. Daniel Weintraub discuss the risks associated with the development of dementia in patients diagnosed with Parkinson disease.

Show reference:

https://www.neurology.org/doi/10.1212/WNL.0000000000209699

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss why clinicians should be cautious when relying too much on dopaminergic imaging.

Show reference:

https://doi.org/10.1212/WNL.0000000000209453

In part two of this two-part series, Dr. Tesha Monteith discusses the key features of long COVID.

Show reference:

https://doi.org/10.17226/27768

In part one of this two-part series, Dr. Tesha Monteith discusses the 2024 National Academies of Sciences, Engineering, and Medicine formal definition of long COVID.

Show reference:

https://doi.org/10.17226/27768

Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss the strengths of dopamine transporter imaging or DAT imaging in diagnosing patients with Parkinsonian disorders.

Show references:

https://doi.org/10.1212/WNL.0000000000209453

Dr. Dan Ackerman and Dr. Luciano A. Sposato discuss the topic of embolic stroke of undetermined sources and the controversies surrounding cardiac monitoring and anticoagulation.

Show reference:

https://www.neurology.org/doi/10.1212/WNL.0000000000209535

Dr. Tesha Monteith provides an overview of the updated position statement on migraine prevention by the American Headache Society.

In part two of this two-part series, Dr. Dan Ackerman and Dr. Gaspard Gerschenfeld discuss the differences in treatment between American Stroke Centers and those in France.

Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209398

Dr. Meagan Seay discusses a relatively recently described but very interesting phenomenon called transient smartphone blindness. This is a phenomenon causing acute, painless, transient, monocular vision loss associated with smartphone use while lying down in the dark.

Show reference:

Transient Smartphone Blindness - EyeWiki